1. Home
  2. MAZE vs BNED Comparison

MAZE vs BNED Comparison

Compare MAZE & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAZE
  • BNED
  • Stock Information
  • Founded
  • MAZE 2018
  • BNED 1965
  • Country
  • MAZE United States
  • BNED United States
  • Employees
  • MAZE N/A
  • BNED N/A
  • Industry
  • MAZE
  • BNED Other Specialty Stores
  • Sector
  • MAZE
  • BNED Consumer Discretionary
  • Exchange
  • MAZE NYSE
  • BNED Nasdaq
  • Market Cap
  • MAZE 367.0M
  • BNED 371.2M
  • IPO Year
  • MAZE 2025
  • BNED N/A
  • Fundamental
  • Price
  • MAZE $13.07
  • BNED $11.83
  • Analyst Decision
  • MAZE Strong Buy
  • BNED
  • Analyst Count
  • MAZE 3
  • BNED 0
  • Target Price
  • MAZE $25.67
  • BNED N/A
  • AVG Volume (30 Days)
  • MAZE 95.0K
  • BNED 376.6K
  • Earning Date
  • MAZE 05-14-2025
  • BNED 06-30-2025
  • Dividend Yield
  • MAZE N/A
  • BNED N/A
  • EPS Growth
  • MAZE N/A
  • BNED N/A
  • EPS
  • MAZE 0.34
  • BNED N/A
  • Revenue
  • MAZE $167,500,000.00
  • BNED $1,567,800,000.00
  • Revenue This Year
  • MAZE N/A
  • BNED $2.74
  • Revenue Next Year
  • MAZE N/A
  • BNED N/A
  • P/E Ratio
  • MAZE $39.80
  • BNED N/A
  • Revenue Growth
  • MAZE N/A
  • BNED N/A
  • 52 Week Low
  • MAZE $6.71
  • BNED $6.05
  • 52 Week High
  • MAZE $17.00
  • BNED $39.47
  • Technical
  • Relative Strength Index (RSI)
  • MAZE N/A
  • BNED 64.95
  • Support Level
  • MAZE N/A
  • BNED $11.59
  • Resistance Level
  • MAZE N/A
  • BNED $12.15
  • Average True Range (ATR)
  • MAZE 0.00
  • BNED 0.41
  • MACD
  • MAZE 0.00
  • BNED 0.04
  • Stochastic Oscillator
  • MAZE 0.00
  • BNED 83.83

About MAZE MAZE THERAPEUTICS INC

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: